The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
125820812 12582081 2 F 20160520 20160808 20160722 20160810 EXP FR-ROCHE-1796719 ROCHE 80.00 YR F Y 0.00000 20160810 MD FR FR

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
125820812 12582081 1 PS MABTHERA RITUXIMAB 1 Intravenous drip LAST CYCLE OF CHEMOTHERAPY WAS ADMINISTRATED IN APR/2016.?8 CYCLES 103705 SOLUTION FOR INFUSION
125820812 12582081 2 C ADRIBLASTINE DOXORUBICIN 1 Intravenous drip LAST CYCLE OF CHEMOTHERAPY WAS ADMINISTRATED IN APR/2016.?8 CYCLES 0
125820812 12582081 3 C ENDOXAN CYCLOPHOSPHAMIDE 1 Intravenous drip LAST CYCLE OF CHEMOTHERAPY WAS ADMINISTRATED IN APR/2016.?8 CYCLES 0
125820812 12582081 4 C ONCOVIN VINCRISTINE SULFATE 1 Intravenous drip LAST CYCLE OF CHEMOTHERAPY WAS ADMINISTRATED IN APR/2016.?8 CYCLES 0
125820812 12582081 5 C PREDNISOLONE. PREDNISOLONE 1 Oral LAST CYCLE OF CHEMOTHERAPY WAS ADMINISTRATED IN APR/2016.?8 CYCLES 0
125820812 12582081 6 C ZELITREX VALACYCLOVIR HYDROCHLORIDE 1 Oral 0 500 MG Q12H
125820812 12582081 7 C BACTRIM SULFAMETHOXAZOLETRIMETHOPRIM 1 Oral 0 TABLET
125820812 12582081 8 C APIXABAN APIXABAN 1 Unknown 0 2.5 MG Q12H
125820812 12582081 9 C AMLODIPINE AMLODIPINE BESYLATE 1 Oral 0 5 MG BID
125820812 12582081 10 C PARACETAMOL ACETAMINOPHEN 1 Oral 0 500 MG
125820812 12582081 11 C MACROGOL POLYETHYLENE GLYCOLS 1 Oral 0 1 DF QD
125820812 12582081 12 C ESOMEPRAZOLE ESOMEPRAZOLE 1 Oral 0 40 MG QD
125820812 12582081 13 C STILNOX ZOLPIDEM TARTRATE 1 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
125820812 12582081 1 Diffuse large B-cell lymphoma
125820812 12582081 2 Diffuse large B-cell lymphoma
125820812 12582081 3 Diffuse large B-cell lymphoma
125820812 12582081 4 Diffuse large B-cell lymphoma
125820812 12582081 5 Diffuse large B-cell lymphoma

Outcome of event

Event ID CASEID OUTC COD
125820812 12582081 DE
125820812 12582081 LT

Reactions reported

Event ID CASEID DRUG REC ACT PT
125820812 12582081 Altered state of consciousness
125820812 12582081 Asthenia
125820812 12582081 Balance disorder
125820812 12582081 Dysarthria
125820812 12582081 Dysphagia
125820812 12582081 General physical health deterioration
125820812 12582081 Oral fungal infection
125820812 12582081 Orthostatic hypotension
125820812 12582081 Progressive multifocal leukoencephalopathy
125820812 12582081 Psychomotor skills impaired

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
125820812 12582081 1 201511 201604 0
125820812 12582081 2 201511 201604 0
125820812 12582081 3 201511 201604 0
125820812 12582081 4 201511 201604 0
125820812 12582081 5 201511 201604 0